Since TIMAP is also predominantly expressed in the nervous system [21, 23] and is a prognostic marker in glioblastoma multiform [27] and head and neck cancer [23, 26], it is plausible that it might be associated with PAK3 regulation. Here, PPP1R16B is linked to glioblastoma.